Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.061 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.065 | 0.7 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.061 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |